Videos de Experimentos Relacionados
Bromontan, un nuevo agente de dopaje.
Lancet (London, England)
|October 7, 1997
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Integrative multidisciplinary approaches by the Integrative Medicine Research Group (IMRG): a new frontier in cancer setting.
European review for medical and pharmacological sciences·2023
Same author
[First French-speaking days of users of decision support system in clinical pharmacy: Feedback and perspectives].
Annales pharmaceutiques francaises·2023
Same author
Biochemical analysis of cerebrospinal fluid in the laboratories of deployed medical treatment facilities: are Multistix 10 SG strip and iSTAT useful?
Journal of the Royal Army Medical Corps·2017
Same author
[Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2016
Same author
[The VR, the Russian version of the nerve agent VX].
Annales pharmaceutiques francaises·2015
Same author
Excitatory and inhibitory amino acids involved in the high pressure nervous syndrome: Epileptic activity and hyperexcitability.
Amino acids·2013
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026
Same journal
Dual mobility total hip replacement in fractures: stability promotes patient confidence.
Lancet (London, England)·2026